Free Trial
BATS:ARKG

ARK Genomic Revolution ETF (ARKG) Price, Holdings, & News

ARK Genomic Revolution ETF logo
$25.95 +2.34 (+9.92%)
As of 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ARK Genomic Revolution ETF (BATS:ARKG)

Key Stats

Today's Range
$24.20
$25.24
50-Day Range
$22.66
$26.69
52-Week Range
N/A
Volume
4.90 million shs
Average Volume
N/A
Market Capitalization
$1.47 billion
Assets Under Management
$1.10 billion
Dividend Yield
N/A
Net Expense Ratio
0.75%
Aggregate Rating
Moderate Buy

ETF Overview

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

ARK Genomic Revolution ETF Expenses

TypeARKGTheme ETFsEquity ETFsBATS ETFsAll ETFs
Management Fee0.75%0.57%0.55%0.57%0.52%
Other Expenses0.00%0.57%0.49%0.46%0.54%
Total Expense0.75%0.73%0.71%0.69%0.71%
Fee Waiver0.00%-0.73%-0.51%-0.35%-0.56%
Net Expense0.75%0.60%0.61%0.64%0.59%
Receive ARKG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARK Genomic Revolution ETF and its competitors with MarketBeat's FREE daily newsletter.

ARKG ETF News Headlines

URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode.
Unusually active option classes on open November 25th
Unusually active option classes on open November 14th
See More Headlines

ARKG ETF - Frequently Asked Questions

ARK Genomic Revolution ETF's stock was trading at $23.5450 on January 1st, 2025. Since then, ARKG shares have increased by 10.2% and is now trading at $25.9510.
View the best growth stocks for 2025 here
.

Top institutional investors of ARK Genomic Revolution ETF include Krilogy Financial LLC (0.21%), Elmwood Wealth Management Inc. (0.11%), Brookstone Capital Management (0.10%) and Ameritas Advisory Services LLC (0.07%).

Shares of ARKG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARK Genomic Revolution ETF investors own include Invesco QQQ (QQQ), ARK Innovation ETF (ARKK), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), AbbVie (ABBV) and PayPal (PYPL).

Fund Details

Issuer
ARK
Fund Name
ARK Genomic Revolution ETF
Tax Classification
Regulated Investment Company
Inception Date
10/31/2014
Fund Manager
Catherine Wood
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
N/A
Category
Strategy
Focus
Theme
Development Level
Blended Development
Region
Global
Number of Holdings
37

Fund Statistics

Assets Under Management
$1.10 billion
Average Daily Volume
$3.39 million
Discount/Premium
-0.03%

Administrator, Advisor and Custodian

Administrator
The Bank of NewYork Mellon Corporation
Advisor
ARK Investment Management LLC
Custodian
The Bank of NewYork Mellon Corporation
Distributor
Foreside Fund Services, LLC
Transfer Agent
The Bank of NewYork Mellon Corporation
Trustee
N/A
Lead Market Maker
Jane Street

Options

Optionable
Optionable
Options Volume
93,682
Put Options
47,718
Call Options
45,964

Miscellaneous

Beta
1.99
Creation Unit
50,000
Creation Fee
$500.00
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Top 10 ARKG Holdings

ARKG Sector Exposure

ARKG Industry Exposure


This page (BATS:ARKG) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners